Condition

Heparin Induced Thrombocytopenia (2)

Thrombocytopenia, Immune (1)

Overall Status

Completed (1)

Not yet recruiting (1)

Sign in for free

Phase

phase 2 (1)

Sponsor

HealthCore-NERI (1)

Veralox Therapeutics (1)

Collaborator

National Heart, Lung, and Blood Institute (NHLBI) (1)

Intervention

placebo (1)

vlx-1005 (1)

Study Documents

Intervention Type

drug (1)

Funder Type

Industry (1)

Other (1)

Study Type

Interventional (1)

Observational (1)

heparin induced thrombocytopenia

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Thrombocytopenia, Immune, Heparin Induced Thrombocytopenia Trial (VLX-1005, Placebo)

Not yet recruiting

Thrombocytopenia, Immune
Heparin Induced Thrombocytopenia

VLX-1005
Placebo

(no location specified)

Mar 24, 2023

Heparin-Induced Thrombocytopenia - Retrospective Analysis of

Completed

Heparin Induced Thrombocytopenia

Iowa City, Iowa
+20 more

May 6, 2015